Alexandra Hafner, MS SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 3951 Rt. 212, Lake Hill, NY 12448 Phone: 845-679-6930 |
News Archive
Osiris Therapeutics, Inc. announced today that the Biologics and Genetic Therapies Directorate of Health Canada has completed its initial evaluation and accepted for full review the company's New Drug Submission (NDS) of Prochymal (remestemcel-L), an adult stem cell therapy for the treatment of graft vs. host disease (GvHD). Based on a separate review of summary clinical data, Health Canada has notified Osiris that the application has been granted Priority Review, shortening the examination period from 300 to 180 days.
The Bill & Melinda Gates Foundation today announced 88 new winners of US$100,000 each to support innovative research that has the potential to dramatically improve lives in some of the world's poorest countries. The funding, made possible through the Grand Challenges Exploration (GCE) program, will enable researchers worldwide to test unorthodox ideas that address persistent health and development challenges.
The Food and Drug Administration in the U.S. have issued strong warnings concerning the use of the antibiotic drug Tequin.
Republican politicians are touting the virtues of market competition and calling for a "premium support" plan that would give beneficiaries a set amount of money to shop among private plans for their own insurance. What they do not say is that private plans have long been more costly than traditional Medicare and have shown far less ability to slow spending.
California officials worry that highly publicized problems of the federal website will scare customers away from the state marketplace, which is open for business. Meanwhile, news outlets look at issues in New York, Connecticut, Texas and Minnesota.
› Verified 8 days ago